Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sustained Release Injectables Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Microparticles
1.2.3 Implants
1.2.4 Gels
1.3 Market by Application
1.3.1 Global Sustained Release Injectables Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Ophthalmology
1.3.6 CNS
1.3.7 Rheumatology
1.3.8 Oncology
1.3.9 Reproductive Health
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sustained Release Injectables Market Perspective (2018-2034)
2.2 Sustained Release Injectables Growth Trends by Region
2.2.1 Global Sustained Release Injectables Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Sustained Release Injectables Historic Market Size by Region (2018-2024)
2.2.3 Sustained Release Injectables Forecasted Market Size by Region (2024-2034)
2.3 Sustained Release Injectables Market Dynamics
2.3.1 Sustained Release Injectables Industry Trends
2.3.2 Sustained Release Injectables Market Drivers
2.3.3 Sustained Release Injectables Market Challenges
2.3.4 Sustained Release Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sustained Release Injectables Players by Revenue
3.1.1 Global Top Sustained Release Injectables Players by Revenue (2018-2024)
3.1.2 Global Sustained Release Injectables Revenue Market Share by Players (2018-2024)
3.2 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sustained Release Injectables Revenue
3.4 Global Sustained Release Injectables Market Concentration Ratio
3.4.1 Global Sustained Release Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sustained Release Injectables Revenue in 2022
3.5 Sustained Release Injectables Key Players Head office and Area Served
3.6 Key Players Sustained Release Injectables Product Solution and Service
3.7 Date of Enter into Sustained Release Injectables Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sustained Release Injectables Breakdown Data by Type
4.1 Global Sustained Release Injectables Historic Market Size by Type (2018-2024)
4.2 Global Sustained Release Injectables Forecasted Market Size by Type (2024-2034)
5 Sustained Release Injectables Breakdown Data by Application
5.1 Global Sustained Release Injectables Historic Market Size by Application (2018-2024)
5.2 Global Sustained Release Injectables Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Sustained Release Injectables Market Size (2018-2034)
6.2 North America Sustained Release Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Sustained Release Injectables Market Size by Country (2018-2024)
6.4 North America Sustained Release Injectables Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sustained Release Injectables Market Size (2018-2034)
7.2 Europe Sustained Release Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Sustained Release Injectables Market Size by Country (2018-2024)
7.4 Europe Sustained Release Injectables Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sustained Release Injectables Market Size (2018-2034)
8.2 Asia-Pacific Sustained Release Injectables Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Sustained Release Injectables Market Size by Region (2018-2024)
8.4 Asia-Pacific Sustained Release Injectables Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sustained Release Injectables Market Size (2018-2034)
9.2 Latin America Sustained Release Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Sustained Release Injectables Market Size by Country (2018-2024)
9.4 Latin America Sustained Release Injectables Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sustained Release Injectables Market Size (2018-2034)
10.2 Middle East & Africa Sustained Release Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Sustained Release Injectables Market Size by Country (2018-2024)
10.4 Middle East & Africa Sustained Release Injectables Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AntriaBio
11.1.1 AntriaBio Company Detail
11.1.2 AntriaBio Business Overview
11.1.3 AntriaBio Sustained Release Injectables Introduction
11.1.4 AntriaBio Revenue in Sustained Release Injectables Business (2018-2024)
11.1.5 AntriaBio Recent Development
11.2 Ascendis Pharma
11.2.1 Ascendis Pharma Company Detail
11.2.2 Ascendis Pharma Business Overview
11.2.3 Ascendis Pharma Sustained Release Injectables Introduction
11.2.4 Ascendis Pharma Revenue in Sustained Release Injectables Business (2018-2024)
11.2.5 Ascendis Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Sustained Release Injectables Introduction
11.3.4 AstraZeneca Revenue in Sustained Release Injectables Business (2018-2024)
11.3.5 AstraZeneca Recent Development
11.4 Aurobindo
11.4.1 Aurobindo Company Detail
11.4.2 Aurobindo Business Overview
11.4.3 Aurobindo Sustained Release Injectables Introduction
11.4.4 Aurobindo Revenue in Sustained Release Injectables Business (2018-2024)
11.4.5 Aurobindo Recent Development
11.5 Avadel
11.5.1 Avadel Company Detail
11.5.2 Avadel Business Overview
11.5.3 Avadel Sustained Release Injectables Introduction
11.5.4 Avadel Revenue in Sustained Release Injectables Business (2018-2024)
11.5.5 Avadel Recent Development
11.6 Alkermes
11.6.1 Alkermes Company Detail
11.6.2 Alkermes Business Overview
11.6.3 Alkermes Sustained Release Injectables Introduction
11.6.4 Alkermes Revenue in Sustained Release Injectables Business (2018-2024)
11.6.5 Alkermes Recent Development
11.7 Amylin Pharmaceuticals
11.7.1 Amylin Pharmaceuticals Company Detail
11.7.2 Amylin Pharmaceuticals Business Overview
11.7.3 Amylin Pharmaceuticals Sustained Release Injectables Introduction
11.7.4 Amylin Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024)
11.7.5 Amylin Pharmaceuticals Recent Development
11.8 Biomarin
11.8.1 Biomarin Company Detail
11.8.2 Biomarin Business Overview
11.8.3 Biomarin Sustained Release Injectables Introduction
11.8.4 Biomarin Revenue in Sustained Release Injectables Business (2018-2024)
11.8.5 Biomarin Recent Development
11.9 Camurus
11.9.1 Camurus Company Detail
11.9.2 Camurus Business Overview
11.9.3 Camurus Sustained Release Injectables Introduction
11.9.4 Camurus Revenue in Sustained Release Injectables Business (2018-2024)
11.9.5 Camurus Recent Development
11.10 Critical Pharmaceuticals
11.10.1 Critical Pharmaceuticals Company Detail
11.10.2 Critical Pharmaceuticals Business Overview
11.10.3 Critical Pharmaceuticals Sustained Release Injectables Introduction
11.10.4 Critical Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024)
11.10.5 Critical Pharmaceuticals Recent Development
11.11 Durect
11.11.1 Durect Company Detail
11.11.2 Durect Business Overview
11.11.3 Durect Sustained Release Injectables Introduction
11.11.4 Durect Revenue in Sustained Release Injectables Business (2018-2024)
11.11.5 Durect Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Detail
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Sustained Release Injectables Introduction
11.12.4 Eli Lilly Revenue in Sustained Release Injectables Business (2018-2024)
11.12.5 Eli Lilly Recent Development
11.13 Enzon
11.13.1 Enzon Company Detail
11.13.2 Enzon Business Overview
11.13.3 Enzon Sustained Release Injectables Introduction
11.13.4 Enzon Revenue in Sustained Release Injectables Business (2018-2024)
11.13.5 Enzon Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Detail
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Sustained Release Injectables Introduction
11.14.4 Ipsen Revenue in Sustained Release Injectables Business (2018-2024)
11.14.5 Ipsen Recent Development
11.15 InnoCore Pharmaceuticals
11.15.1 InnoCore Pharmaceuticals Company Detail
11.15.2 InnoCore Pharmaceuticals Business Overview
11.15.3 InnoCore Pharmaceuticals Sustained Release Injectables Introduction
11.15.4 InnoCore Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024)
11.15.5 InnoCore Pharmaceuticals Recent Development
11.16 Janssen
11.16.1 Janssen Company Detail
11.16.2 Janssen Business Overview
11.16.3 Janssen Sustained Release Injectables Introduction
11.16.4 Janssen Revenue in Sustained Release Injectables Business (2018-2024)
11.16.5 Janssen Recent Development
11.17 Merck
11.17.1 Merck Company Detail
11.17.2 Merck Business Overview
11.17.3 Merck Sustained Release Injectables Introduction
11.17.4 Merck Revenue in Sustained Release Injectables Business (2018-2024)
11.17.5 Merck Recent Development
11.18 NanOlogy
11.18.1 NanOlogy Company Detail
11.18.2 NanOlogy Business Overview
11.18.3 NanOlogy Sustained Release Injectables Introduction
11.18.4 NanOlogy Revenue in Sustained Release Injectables Business (2018-2024)
11.18.5 NanOlogy Recent Development
11.19 Novartis
11.19.1 Novartis Company Detail
11.19.2 Novartis Business Overview
11.19.3 Novartis Sustained Release Injectables Introduction
11.19.4 Novartis Revenue in Sustained Release Injectables Business (2018-2024)
11.19.5 Novartis Recent Development
11.20 Oakwood Laboratories/PharmaSophia
11.20.1 Oakwood Laboratories/PharmaSophia Company Detail
11.20.2 Oakwood Laboratories/PharmaSophia Business Overview
11.20.3 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Introduction
11.20.4 Oakwood Laboratories/PharmaSophia Revenue in Sustained Release Injectables Business (2018-2024)
11.20.5 Oakwood Laboratories/PharmaSophia Recent Development
11.21 OctoPlus
11.21.1 OctoPlus Company Detail
11.21.2 OctoPlus Business Overview
11.21.3 OctoPlus Sustained Release Injectables Introduction
11.21.4 OctoPlus Revenue in Sustained Release Injectables Business (2018-2024)
11.21.5 OctoPlus Recent Development
11.22 Pacira
11.22.1 Pacira Company Detail
11.22.2 Pacira Business Overview
11.22.3 Pacira Sustained Release Injectables Introduction
11.22.4 Pacira Revenue in Sustained Release Injectables Business (2018-2024)
11.22.5 Pacira Recent Development
11.23 PhaseBio Pharmaceuticals
11.23.1 PhaseBio Pharmaceuticals Company Detail
11.23.2 PhaseBio Pharmaceuticals Business Overview
11.23.3 PhaseBio Pharmaceuticals Sustained Release Injectables Introduction
11.23.4 PhaseBio Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024)
11.23.5 PhaseBio Pharmaceuticals Recent Development
11.24 Recipharm AB
11.24.1 Recipharm AB Company Detail
11.24.2 Recipharm AB Business Overview
11.24.3 Recipharm AB Sustained Release Injectables Introduction
11.24.4 Recipharm AB Revenue in Sustained Release Injectables Business (2018-2024)
11.24.5 Recipharm AB Recent Development
11.25 Roche
11.25.1 Roche Company Detail
11.25.2 Roche Business Overview
11.25.3 Roche Sustained Release Injectables Introduction
11.25.4 Roche Revenue in Sustained Release Injectables Business (2018-2024)
11.25.5 Roche Recent Development
11.26 Sanofi
11.26.1 Sanofi Company Detail
11.26.2 Sanofi Business Overview
11.26.3 Sanofi Sustained Release Injectables Introduction
11.26.4 Sanofi Revenue in Sustained Release Injectables Business (2018-2024)
11.26.5 Sanofi Recent Development
11.27 Taiwan Liposome Company (TLC)
11.27.1 Taiwan Liposome Company (TLC) Company Detail
11.27.2 Taiwan Liposome Company (TLC) Business Overview
11.27.3 Taiwan Liposome Company (TLC) Sustained Release Injectables Introduction
11.27.4 Taiwan Liposome Company (TLC) Revenue in Sustained Release Injectables Business (2018-2024)
11.27.5 Taiwan Liposome Company (TLC) Recent Development
11.28 Xbrane Biopharma
11.28.1 Xbrane Biopharma Company Detail
11.28.2 Xbrane Biopharma Business Overview
11.28.3 Xbrane Biopharma Sustained Release Injectables Introduction
11.28.4 Xbrane Biopharma Revenue in Sustained Release Injectables Business (2018-2024)
11.28.5 Xbrane Biopharma Recent Development
11.29 Livzon Pharm
11.29.1 Livzon Pharm Company Detail
11.29.2 Livzon Pharm Business Overview
11.29.3 Livzon Pharm Sustained Release Injectables Introduction
11.29.4 Livzon Pharm Revenue in Sustained Release Injectables Business (2018-2024)
11.29.5 Livzon Pharm Recent Development
11.30 Luye Pharma Group
11.30.1 Luye Pharma Group Company Detail
11.30.2 Luye Pharma Group Business Overview
11.30.3 Luye Pharma Group Sustained Release Injectables Introduction
11.30.4 Luye Pharma Group Revenue in Sustained Release Injectables Business (2018-2024)
11.30.5 Luye Pharma Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sustained Release Injectables Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Microparticles
Table 3. Key Players of Implants
Table 4. Key Players of Gels
Table 5. Global Sustained Release Injectables Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Sustained Release Injectables Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Sustained Release Injectables Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Sustained Release Injectables Market Share by Region (2018-2024)
Table 9. Global Sustained Release Injectables Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Sustained Release Injectables Market Share by Region (2024-2034)
Table 11. Sustained Release Injectables Market Trends
Table 12. Sustained Release Injectables Market Drivers
Table 13. Sustained Release Injectables Market Challenges
Table 14. Sustained Release Injectables Market Restraints
Table 15. Global Sustained Release Injectables Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Sustained Release Injectables Market Share by Players (2018-2024)
Table 17. Global Top Sustained Release Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2022)
Table 18. Ranking of Global Top Sustained Release Injectables Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sustained Release Injectables Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sustained Release Injectables Product Solution and Service
Table 22. Date of Enter into Sustained Release Injectables Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sustained Release Injectables Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Sustained Release Injectables Revenue Market Share by Type (2018-2024)
Table 26. Global Sustained Release Injectables Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Sustained Release Injectables Revenue Market Share by Type (2024-2034)
Table 28. Global Sustained Release Injectables Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Sustained Release Injectables Revenue Market Share by Application (2018-2024)
Table 30. Global Sustained Release Injectables Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Sustained Release Injectables Revenue Market Share by Application (2024-2034)
Table 32. North America Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Sustained Release Injectables Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Sustained Release Injectables Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. Europe Sustained Release Injectables Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Sustained Release Injectables Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Sustained Release Injectables Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Asia-Pacific Sustained Release Injectables Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Sustained Release Injectables Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Latin America Sustained Release Injectables Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Sustained Release Injectables Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Sustained Release Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Middle East & Africa Sustained Release Injectables Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Sustained Release Injectables Market Size by Country (2024-2034) & (US$ Million)
Table 47. AntriaBio Company Detail
Table 48. AntriaBio Business Overview
Table 49. AntriaBio Sustained Release Injectables Product
Table 50. AntriaBio Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 51. AntriaBio Recent Development
Table 52. Ascendis Pharma Company Detail
Table 53. Ascendis Pharma Business Overview
Table 54. Ascendis Pharma Sustained Release Injectables Product
Table 55. Ascendis Pharma Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 56. Ascendis Pharma Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Sustained Release Injectables Product
Table 60. AstraZeneca Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Aurobindo Company Detail
Table 63. Aurobindo Business Overview
Table 64. Aurobindo Sustained Release Injectables Product
Table 65. Aurobindo Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 66. Aurobindo Recent Development
Table 67. Avadel Company Detail
Table 68. Avadel Business Overview
Table 69. Avadel Sustained Release Injectables Product
Table 70. Avadel Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 71. Avadel Recent Development
Table 72. Alkermes Company Detail
Table 73. Alkermes Business Overview
Table 74. Alkermes Sustained Release Injectables Product
Table 75. Alkermes Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 76. Alkermes Recent Development
Table 77. Amylin Pharmaceuticals Company Detail
Table 78. Amylin Pharmaceuticals Business Overview
Table 79. Amylin Pharmaceuticals Sustained Release Injectables Product
Table 80. Amylin Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 81. Amylin Pharmaceuticals Recent Development
Table 82. Biomarin Company Detail
Table 83. Biomarin Business Overview
Table 84. Biomarin Sustained Release Injectables Product
Table 85. Biomarin Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 86. Biomarin Recent Development
Table 87. Camurus Company Detail
Table 88. Camurus Business Overview
Table 89. Camurus Sustained Release Injectables Product
Table 90. Camurus Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 91. Camurus Recent Development
Table 92. Critical Pharmaceuticals Company Detail
Table 93. Critical Pharmaceuticals Business Overview
Table 94. Critical Pharmaceuticals Sustained Release Injectables Product
Table 95. Critical Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 96. Critical Pharmaceuticals Recent Development
Table 97. Durect Company Detail
Table 98. Durect Business Overview
Table 99. Durect Sustained Release Injectables Product
Table 100. Durect Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 101. Durect Recent Development
Table 102. Eli Lilly Company Detail
Table 103. Eli Lilly Business Overview
Table 104. Eli Lilly Sustained Release Injectables Product
Table 105. Eli Lilly Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 106. Eli Lilly Recent Development
Table 107. Enzon Company Detail
Table 108. Enzon Business Overview
Table 109. Enzon Sustained Release Injectables Product
Table 110. Enzon Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 111. Enzon Recent Development
Table 112. Ipsen Company Detail
Table 113. Ipsen Business Overview
Table 114. Ipsen Sustained Release Injectables Product
Table 115. Ipsen Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 116. Ipsen Recent Development
Table 117. InnoCore Pharmaceuticals Company Detail
Table 118. InnoCore Pharmaceuticals Business Overview
Table 119. InnoCore Pharmaceuticals Sustained Release Injectables Product
Table 120. InnoCore Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 121. InnoCore Pharmaceuticals Recent Development
Table 122. Janssen Company Detail
Table 123. Janssen Business Overview
Table 124. Janssen Sustained Release Injectables Product
Table 125. Janssen Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 126. Janssen Recent Development
Table 127. Merck Company Detail
Table 128. Merck Business Overview
Table 129. Merck Sustained Release Injectables Product
Table 130. Merck Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 131. Merck Recent Development
Table 132. NanOlogy Company Detail
Table 133. NanOlogy Business Overview
Table 134. NanOlogy Sustained Release Injectables Product
Table 135. NanOlogy Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 136. NanOlogy Recent Development
Table 137. Novartis Company Detail
Table 138. Novartis Business Overview
Table 139. Novartis Sustained Release Injectables Product
Table 140. Novartis Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 141. Novartis Recent Development
Table 142. Oakwood Laboratories/PharmaSophia Company Detail
Table 143. Oakwood Laboratories/PharmaSophia Business Overview
Table 144. Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product
Table 145. Oakwood Laboratories/PharmaSophia Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 146. Oakwood Laboratories/PharmaSophia Recent Development
Table 147. OctoPlus Company Detail
Table 148. OctoPlus Business Overview
Table 149. OctoPlus Sustained Release Injectables Product
Table 150. OctoPlus Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 151. OctoPlus Recent Development
Table 152. Pacira Company Detail
Table 153. Pacira Business Overview
Table 154. Pacira Sustained Release Injectables Product
Table 155. Pacira Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 156. Pacira Recent Development
Table 157. PhaseBio Pharmaceuticals Company Detail
Table 158. PhaseBio Pharmaceuticals Business Overview
Table 159. PhaseBio Pharmaceuticals Sustained Release Injectables Product
Table 160. PhaseBio Pharmaceuticals Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 161. PhaseBio Pharmaceuticals Recent Development
Table 162. Recipharm AB Company Detail
Table 163. Recipharm AB Business Overview
Table 164. Recipharm AB Sustained Release Injectables Product
Table 165. Recipharm AB Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 166. Recipharm AB Recent Development
Table 167. Roche Company Detail
Table 168. Roche Business Overview
Table 169. Roche Sustained Release Injectables Product
Table 170. Roche Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 171. Roche Recent Development
Table 172. Sanofi Company Detail
Table 173. Sanofi Business Overview
Table 174. Sanofi Sustained Release Injectables Product
Table 175. Sanofi Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 176. Sanofi Recent Development
Table 177. Taiwan Liposome Company (TLC) Company Detail
Table 178. Taiwan Liposome Company (TLC) Business Overview
Table 179. Taiwan Liposome Company (TLC) Sustained Release Injectables Product
Table 180. Taiwan Liposome Company (TLC) Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 181. Taiwan Liposome Company (TLC) Recent Development
Table 182. Xbrane Biopharma Company Detail
Table 183. Xbrane Biopharma Business Overview
Table 184. Xbrane Biopharma Sustained Release Injectables Product
Table 185. Xbrane Biopharma Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 186. Xbrane Biopharma Recent Development
Table 187. Livzon Pharm Company Detail
Table 188. Livzon Pharm Business Overview
Table 189. Livzon Pharm Sustained Release Injectables Product
Table 190. Livzon Pharm Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 191. Livzon Pharm Recent Development
Table 192. Luye Pharma Group Company Detail
Table 193. Luye Pharma Group Business Overview
Table 194. Luye Pharma Group Sustained Release Injectables Product
Table 195. Luye Pharma Group Revenue in Sustained Release Injectables Business (2018-2024) & (US$ Million)
Table 196. Luye Pharma Group Recent Development
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sustained Release Injectables Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Sustained Release Injectables Market Share by Type: 2022 VS 2034
Figure 3. Microparticles Features
Figure 4. Implants Features
Figure 5. Gels Features
Figure 6. Global Sustained Release Injectables Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Sustained Release Injectables Market Share by Application: 2022 VS 2034
Figure 8. Diabetes Case Studies
Figure 9. Leukemia Case Studies
Figure 10. Acromegaly Case Studies
Figure 11. Ophthalmology Case Studies
Figure 12. CNS Case Studies
Figure 13. Rheumatology Case Studies
Figure 14. Oncology Case Studies
Figure 15. Reproductive Health Case Studies
Figure 16. Others Case Studies
Figure 17. Sustained Release Injectables Report Years Considered
Figure 18. Global Sustained Release Injectables Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 19. Global Sustained Release Injectables Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 20. Global Sustained Release Injectables Market Share by Region: 2022 VS 2034
Figure 21. Global Sustained Release Injectables Market Share by Players in 2022
Figure 22. Global Top Sustained Release Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Sustained Release Injectables Revenue in 2022
Figure 24. North America Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. North America Sustained Release Injectables Market Share by Country (2018-2034)
Figure 26. United States Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Canada Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Europe Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Europe Sustained Release Injectables Market Share by Country (2018-2034)
Figure 30. Germany Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. France Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. U.K. Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Italy Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Russia Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Nordic Countries Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Asia-Pacific Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Asia-Pacific Sustained Release Injectables Market Share by Region (2018-2034)
Figure 38. China Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Japan Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. South Korea Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Southeast Asia Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. India Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Australia Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Latin America Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Latin America Sustained Release Injectables Market Share by Country (2018-2034)
Figure 46. Mexico Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Brazil Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Sustained Release Injectables Market Share by Country (2018-2034)
Figure 50. Turkey Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Sustained Release Injectables Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. AntriaBio Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 53. Ascendis Pharma Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 55. Aurobindo Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 56. Avadel Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 57. Alkermes Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 58. Amylin Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 59. Biomarin Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 60. Camurus Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 61. Critical Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 62. Durect Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 63. Eli Lilly Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 64. Enzon Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 65. Ipsen Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 66. InnoCore Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 67. Janssen Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 68. Merck Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 69. NanOlogy Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 70. Novartis Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 71. Oakwood Laboratories/PharmaSophia Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 72. OctoPlus Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 73. Pacira Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 74. PhaseBio Pharmaceuticals Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 75. Recipharm AB Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 76. Roche Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 77. Sanofi Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 78. Taiwan Liposome Company (TLC) Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 79. Xbrane Biopharma Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 80. Livzon Pharm Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 81. Luye Pharma Group Revenue Growth Rate in Sustained Release Injectables Business (2018-2024)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed